|
Industry Input Key to Untying FDA’s Globalization, FDASIA Knots: Official
CINCINNATI — To help the FDA meet new congressional mandates and complex globalization challenges, drugmakers need to shed their fear of reporting supply chain concerns and manufacturing flubs, agency officials say.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives